Kadar Fibrinogen Plasma sebagai Faktor Prognostik Karsinoma Hepatoseluler
Analisis
DOI:
https://doi.org/10.55175/cdk.v52i2.1367Kata Kunci:
Fibrinogen, karsinoma hepatoseluler, prognosisAbstrak
Pendahuluan: Artikel ini bertujuan untuk mengetahui peran kadar fibrinogen plasma sebagai salah satu faktor prognostik penderita karsinoma hepatoseluler. Metode: Pencarian literatur terstruktur melalui PubMed, Google Scholar, dan ScienceDirect sesuai pertanyaan klinis. Pemilihan artikel berdasarkan kriteria inklusi dan eksklusi. Tiga literatur yang terpilih menjalani penilaian kritis berdasarkan kriteria validitas, importance, dan applicability. Pembahasan: Tiga literatur yang ditelaah menyatakan bahwa kadar fibrinogen plasma tinggi berkorelasi dengan buruknya overall survival penderita karsinoma hepatoseluler. Simpulan: Kadar fibrinogen plasma dapat berperan sebagai faktor prognostik overall survival penderita karsinoma hepatoseluler.
Unduhan
Referensi
Carr B. Tumors of liver and biliary tree. In: Kasper D, Hauser S, Fauci A, Jameson J, Loscalzo J, Longo D, editors. Harrison’s principles of internal medicine. New York: McGraw Hill; 2011. p. 544-51.
Roberts L. Liver and biliary tract tumor. In: Goldman L, Schafer A, editors. Goldman-Cecil medicine. Philadelphia: Saunders Elsevier; 2016. p.1481-94.
Caine G, Kehoe S, Stonelake P, Lip G. The hypercoagulable state of malignancy. J Neoplasia. 2012;6:465-74. DOI: 10.1038/sj.neo.7900263.
Collen D, Tygat G, Piessens R, Claeys H. Metabolism and distribution of fibrinogen. Br J Haematol. 1972 Jun;22(6):681-700. DOI: 10.1111/j.1365-2141.1972.tb05715.x.
Centre for Evidence-Based Medicine. Critical appraisal of prognostic studies. Oxford: University of Oxford [Internet]. 2010 [cited 2024 Dec 13]. Available from: https://www.cebm.net/wp-content/uploads/2014/04/cebm-prognosis-worksheet.pdf.
Kinoshita A, Onoda H, Iwaku A, Oishi M, Nami I, Iwaku A, et al. Elevated plasma fibrinogen level is associated with a poor prognosis in hepatocellular carcinoma. Oncology. 2013;85:269-76. DOI: 10.1159/000355502.
Jiang H, Li J, Ge L, Chen P, Shi S, Tang X. Value of plasma fibrinogen and D-dimer in predicting metastasis and recurrence after radical surgery for non-small cell lung cancer. Med Oncol. 2014;32(7):202-8. DOI: 10.1007/s12032-014-0022-8.
Wen J, Yang Y, Ye F, Huang X, Li S, Wang Q, et al. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients. Breast Cancer. 2015;23(6):745-50. DOI: 10.1016/j.breast.2015.09.007.
Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y. Fibrinogen is correlated with advanced cancer stage and poor survival rate in gastric cancer patients undergoing gastrectomy. BMC Cancer. 2016;16:481-92. DOI: 10.1186/s12885-016-2510-z.
Li H, Zhao T, Ji X, Liang S, Wang Z, Yang Y, et al. Hyperfibrinogenemias predict poor outcome in patients with biliary tract cancer. Tumor Biol. 2016;37(3):3535-42. DOI: 10.1007/s13277-015-4184-6.
Waller L, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: A comprehensive review. World J Hepatol. 2015 Nov 18;7(26):2648-63. DOI: 10.4254/wjh.v7.i26.2648.
Byam J, Millis J, Renz J. Liver transplantation for hepatocellular carcinoma: Hepatobiliary Surgery. BMC Cancer 2021;2(1):22-31.
Greten T, Papendorf F, Bleck J, T Kirchhoff, T Wohlberedt, S Kubicka, et al. Survival rate in patient with hepatocellular carcinoma. Br J Cancer. 2005;92(10):1862-9.
Liu Z, Guo H, Gao F, Shan Q, Li J, Xie H, et al. Fibrinogen and D-dimer in hepatocellular carcinoma: High fibrinogen level predicts a poor outcome. Hepatol Res. 2017; 47(11):1108-17. DOI: 10.1111/hepr.12848.
Zhang Q, Long X. Elevated serum plasma fibrinogen is associated with advanced cancer stage and poor survival in hepatocellular carcinoma patients. Medicine (Baltimore). 2017;96(17):694-702. DOI: 10.1097/MD.0000000000006694.
Sheng L, Luo M, Sun X, Lin M, Mao W, Su D, et al. Serum fibrinogen as a prognostic factor in operable cancers. Internat J Cancer. 2020;133(23):2720-5. DOI: 10.1002/ijc.28284.
Sahni S, Simpson-Haidaris PJ, Sahni SK, Vaday G, Francis W. Fibrinogen synthesized by cancer augments the proliferation effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 2008;6:176-84. DOI: 10.1111/j.1538-7836.2007.02808.x.
Francis C, Sami A. Vascular endothelial growth factors bind to fibrinogen and fibrin and stimulate endothelial cell proliferation. Hepatol Res. 2019;96:3772-9. DOI: 10.1182/blood.V96.12.3772.
Zheng S, Shen J, Jiao Y, Liu Y, Chunmei Z, Wei M, et al. Platelet and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci 2009;100(5):859-66. DOI: 10.1111/j.1349-7006.2009.01115.x.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Abdul Jafar Sidik
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
